Clinical Insights: Palforzia is the First FDA-approved Treatment of Peanut AllergyByEllane Guiao, PharmD Candidate,Jonathan Ogurchak, PharmD, CSPOctober 28th 2020Peanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.